REFERENCES
- Focan C. Circadian Rhythms and Cancer Chemotherapy. Pharmacol. Ther. 1995; 67: 1–52
- Lévi F. Circadian Chronotherapy for Human Cancers. Lancet Oncol 2001; 2: 307–315
- Hrushesky W.J.M. Circadian Timing of Cancer Chemotherapy. Science 1985; 228: 73–75
- Lévi F., Zidani R., Misset J.M. A Randomized Multicenter Trial of Chronotherapy with Oxaliplatin, 5-Fluorouracil and Leucovorin in Ambulatory Patients with Metastases from Colorectal Cancer. Lancet 1997; 350: 681–686
- Mormont M.C., Waterhouse J., Bleuzen P., Giacchetti S., Jami A., Bogdan A., Lellouch J., Misset J.L., Touitou Y., Lévi F. Marked 24-h Rest/Activity Rhythms Are Associated with Better Quality of Life, Better Response, and Longer Survival in Patients with Metastatic Colorectal Cancer and Good Performance Status. Clin. Cancer Res. 2000; 6: 3038–3045
- Gregory R.K., Smith I.E. Vinorelbine—a Clinical Review. Br. J. Cancer 2000; 82: 1907–1913
- Lévi F. Chronopharmacology of Anticancer Agents. Physiology and Pharmacology of Biological Rhythms, P.H. Redfern, B. Lemmer. Springer-Verlag, Berlin 1997; 299–331
- Tampellini M., Filipski E., Lévi F. Circadian Variation of Vinorelbine Toxicity in Mice. Chronobiol. Int. 1995; 12: 195–198
- Filipski E., Amat S., Lemaigre G., Vincenti M., Breillout F., Lévi F. Relationship Between Circadian Rhythm of Vinorelbine Toxicity and Efficacy in P388-Bearing Mice. J. Pharmacol. Exp. Ther. 1999; 289: 231–235
- Li X.M., Liu X.H., Filipski E., Metzger G., Delagrange P., Jeanniot J.P., Lévi F. Relationship of Atypical Melatonin Rhythm with Two Circadian Clock Outputs in B6D2F1 Mice. Am. J. Physiol. 2000; 278: R924–R930
- Nelson W., Tong Y., Lee J.K., Halberg F. Methods for Cosinor Rhythmometry. Chronobiologia 1979; 6: 305–323
- Liu X.H., Filipski E., Metzger G., Lévi F. Vinorelbine-Induced G1 Phase Arrest and p53 Overexpression in Mouse Bone Marrow. Relationship with Toxicity Circadian Rhythm. Proc. Am. Assoc. Cancer Res. 1998; 39, #1138 (abs)
- Filipski, E.; Verdun, K.; Li, X. M.; Hasting, M.; Lévi, F. Rest–Activity and Body Temperature Rhythms After Suprachiasmatic Nucleus Destruction in B6D2F1 Mice, Seventh Meeting Society for Research on Biological Rhythm, Florida, USA, May 10–13 (abs), 2000.
- Witte K., Schnecko A., Buijs R.M., Van der Vliet J., Scalbert E., Delagrange P., Guardiola-Lemaître B., Lemmer B. Effects of SCN Lesions on Circadian Blood Pressure Rhythm in Normotensive and Transgenic Hypertensive Rats. Chronobiol. Int. 1998; 15: 135–145
- Li, X. M.; Delagrange, P.; Lévi, F. Melatonin Administration Entrains Circadian Rhythms of Temperature and Activity in B6D2F1 Mice Exposed to Constant Light. In Seventh Meeting Society for Research on Biological Rhythm, Florida, USA, May 10–13 (abs) 2000.
- Sugiyama K., Shimizu M., Akiyama T., Ishida H., Okabe M., Tamaoki T., Akinaga S. Combined Effect of Navelbine with Medroxyprogesterone Acetate Against Human Breast Carcinoma MCF-7 Cells In Vitro. Br. J. Cancer 1998; 77: 1737–1743
- Krucher N.A., Meijer L., Roberts M.H. Cyclin Dependent Kinase Inhibitors Alter the Period and Phase of a Molluscan Circadian Clock. Biological Clocks Mechanisms and Applications, Y. Touitou. Elsevier, Netherlands 1998; 123–126
- van Tellingen O., Kuijpers A.V., Beijnen J.H., Nooijen W.J., Bult A. Plasma Pharmacokinetics, Tissue Disposition, Excretion and Metabolism of Vinorelbine in Mice as Determined by High Performance Liquid Chromatography. Invest. N. Drugs 1993; 11: 141–150
- Mouchard-Delmas C., Gourdier B., Vistelle R., Xiczewski M. Modification of the Blood–Brain Barrier Permeability Following Intracarotid Infusion of Vinorelbine. Anticancer Res. 1995; 15: 1593–1596
- Lévi F., Cornelissen G., Nelson W., Halberg F. Cis-platine Murine Chrononephrotoxicity Gauged by Two Marker Rhythms: Urine Volume and Telemetered Intraperitoneal Temperature. Chronopharmacology, C.A. Walter, K.F.A. Soliman, W. Winger. University Presses of Florida, Tallahassee 1981; 363–377
- Ron I.G., Peleg L., Rienstein S., Dotan A., Ticher A., Wolfson S., Ashkenazi I.E. Time Dependency of Hematopoietic Growth Factor Coupled to Chronotoxicity of Carboplatin. Cancer Chemother. Pharmacol. 1998; 42: 135–141